BarbaraBresnahanMD

PubMed

• 6 citations
  Outcomes at 7 years post-transplant in black vs nonblack kidney transplant recipients administered belatacept or cyclosporine in BENEFIT and BENEFIT-EXT.
  Sander Florman, Flavio Vincenti, Antoine Durrbach, Marwan S Abouljoud, Barbara A. Bresnahan, Valter Duro Garcia, Laura L. Mulloy, Kim Rice, Lionel Rostaing, Carlos Zay...> ;Clinical Transplantation. 2018 Apr 1
• 22 citations
  Efficacy and Safety Outcomes of Extended Criteria Donor Kidneys by Subtype: Subgroup Analysis of BENEFIT-EXT at 7 Years After Transplant.
  Sander Florman, Thomas Becker, Barbara A. Bresnahan, A. Chevaile-Ramos, D. Carvalho, G. Grannas, Ferdinand Muehlbacher, Philip J. O'Connell, H. U. Meier-Kriesche, Chri...> ;American Journal of Transplantation. 2017 Jan 1
• 6 citations
  Large Granular Lymphocytic Leukemia Presenting Late After Solid Organ Transplantation: A Case Series of Four Patients and Review of the Literature
  Ashish Kataria, Eric P. Cohen, Ehab R. Saad, Ehab Atallah, Barbara A. Bresnahan> ;Transplantation Proceedings. 2014 Dec 1
• 135 citations
  Long‐Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long‐Term Extension of the BENEFIT Study
  Lionel Rostaing, Flavio Vincenti, Josep M. Grinyó, K. M. Rice, Barbara A. Bresnahan, Steven M. Steinberg, S. Gang, L. E. Gaite, Marie-Christine Moal, G. A. Mondragón‐R...> ;American Journal of Transplantation. 2013 Nov 1
• 13 citations
  Lower prevalence of BK virus infection in African American renal transplant recipients: a prospective study.
  Puneet Sood, Shamila Senanayake, Kumar Sujeet, Radhika Medipalli, Ehab R. Saad, Brahm Vasudev, Barbara A. Bresnahan, Christopher P. Johnson, Sundaram Hariharan> ;Transplantation. 2012 Feb 15
• 224 citations
  Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients.
  Flavio Vincenti, Christian P. Larsen, Josefina Alberú, Barbara A. Bresnahan, Valter Duro Garcia, J. Kothari, Peter Lang, E. Mancilla Urrea, Pablo U. Massari, G. A. Mon...> ;American Journal of Transplantation. 2012 Jan 1
• 25 citations
  Belatacept-versus Cyclosporine-Based Immunosuppression in Renal Transplant Recipients with Pre-existing Diabetes
  Lionel Rostaing, Hans H. Neumayer, Rafael Reyes-Acevedo, Barbara A. Bresnahan, Sander Florman, Stefan Vitko, Michael Heifets, Jun Xing, Dolca Thomas, Flavio Vincenti> ;Clinical Journal of the American Society of Nephrology. 2011 Nov 1
• 8 citations
  Percussion hemoglobinuria - a novel term for hand trauma-induced mechanical hemolysis: a case report
  M. Vasudev, Barbara A. Bresnahan, Eric P. Cohen, Parameswaran Hari, Sundaram Hariharan, Brahm Vasudev> ;Journal of Medical Case Reports. 2011 Oct 7
• 130 citations
  Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT an...
  Yves Vanrenterghem, Barbara A. Bresnahan, Josep M. Campistol, Antoine Durrbach, Josep M. Grinyó, Hans-Hellmut Neumayer, Philippe Lang, Christian P. Larsen, Eduardo Man...> ;Transplantation. 2011 May 15
• 660 citations
  A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).
  Flavio Vincenti, Bernard Charpentier, Yves Vanrenterghem, Lionel Rostaing, Barbara A. Bresnahan, P. Darji, Pablo U. Massari, G. A. Mondragón‐Ramirez, M. Agarwal, G. Di...> ;American Journal of Transplantation. 2010 Mar 1
• 81 citations
  Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy.
  Ehab R. Saad, Barbara A. Bresnahan, Eric P. Cohen, Na Lu, Rimas J. Orentas, Brahm Vasudev, Sundaram Hariharan> ;Transplantation. 2008 Mar 27
• 15 citations
  Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in renal transplant recipients.
  Diane M. Cibrik, Herwig Ulf Meier-Kriesche, Barbara A. Bresnahan, You Min Wu, Goran B. Klintmalm, Clifton E. Kew, Paul C. Kuo, J. Whelchel, David J. Cohen, Prabakar K....> ;Clinical Transplantation. 2007 Mar 1
• 177 citations
  BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients.
  Brahm Vasudev, Sundaram Hariharan, Syed A. Hussain, Yong-Ran Zhu, Barbara A. Bresnahan, Eric P. Cohen> ;Kidney International. 2005 Oct 1
• 61 citations
  Humanized anti‐CD20 monoclonal antibody (Rituximab) treatment for post‐transplant lymphoproliferative disorder*
  Vasundhara Ganne, Nauman Siddiqi, Bal Kamaplath, Chung-Che Chang, Eric P. Cohen, Barbara A. Bresnahan, Sundaram Hariharan> ;Clinical Transplantation. 2003 Oct 1
• 121 citations
  Expression of TGF-β and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity
  Ashwani Khanna, Matthew S. Plummer, Cathy Bromberek, Barbara A. Bresnahan, Sundaram Hariharan> ;Kidney International. 2002 Dec 1
• 576 citations
  Post-transplant renal function in the first year predicts long-term kidney transplant survival
  Sundaram Hariharan, Maureen A. McBride, Wida S. Cherikh, Christine B. Tolleris, Barbara A. Bresnahan, Christopher P. Johnson> ;Kidney International. 2002 Jul 1
• 16 citations
  A comparison between recipients receiving matched kidney and those receiving mismatched kidney from the same cadaver donor.
  Barbara A. Bresnahan, Christopher P. Johnson, Matthew McIntosh, Donald Stablein, Sundaram Hariharan> ;American Journal of Transplantation. 2002 Apr 1
• 33 citations
  Rapid kidney allograft failure in patients with polyoma virus nephritis with prior treatment with antilymphocyte agents.
  Syed A. Hussain, Barbara A. Bresnahan, Eric P. Cohen, Sundaram Hariharan> ;Clinical Transplantation. 2002 Feb 1
• 101 citations
  Risk factors for renal allograft survival from pediatric cadaver donors: an analysis of united network for organ sharing data.
  Barbara A. Bresnahan, Maureen A. McBride, Wida S. Cherikh, Sundaram Hariharan> ;Transplantation. 2001 Jul 27
• 91 citations
  Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis
  M Ahuja, Eric P. Cohen, Ann M. Dayer, Bal Kampalath, Chung-Che Chang, Barbara A. Bresnahan, Sundaram Hariharan> ;Transplantation. 2001 Apr 15
• 1417 citations
  Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996
  Sundaram Hariharan, Christopher P. Johnson, Barbara A. Bresnahan, S. Taranto, Matthew McIntosh, Donald Stablein> ;The New England Journal of Medicine. 2000 Mar 2
• 14 citations
  Effect of thromboxane A2 inhibition and antagonism on prostaglandin and leukotriene synthesis in glomerular immune injury.
  Elias A. Lianos, Barbara A. Bresnahan> ;The Journal of Laboratory and Clinical Medicine. 1999 Nov 1
• 4 citations
  Changes in glomerular thromboxane A2 receptor expression and ligand binding following immune injury
  Barbara A. Bresnahan, Shelly Dufek, Sheng-Hua Wu, Elias A. Lianos> ;Kidney International. 1999 Jan 1
• 6 citations
  CYTOKINE INHIBITION PRESERVES RENAL HEMODYNAMIC FUNCTION FOLLOWING MESANGIAL CELL IMMUNE INJURY
  Cynthia G. Pan, Barbara A. Bresnahan, C R Albrightson, D Griswold, Elias A. Lianos> ;Journal of Investigative Medicine. 1996 Aug 1
• 22 citations
  Localization of authentic thromboxane A2/prostaglandin H2 receptor in the rat kidney
  Barbara A. Bresnahan, Guy C. Le Breton, Elias A. Lianos> ;Kidney International. 1996 May 1
• Join now to see all